Here you will find recent and archived news about the Meinig School and our affiliates and partners. For more stories, don't forget to browse our spotlights and annual BME newsletters as well!
ACS Central Science article highlights professor Shaoyi Jiang's development of zwitterionic coatings as a safe, economic alternative for mitigating the centuries-old problem of ship fouling. Read more
Bonassar Lab alum Andrea Ippolito (B.S. ’06, M.Eng. '07) will serve on the Biden-Harris Department of Veterans Affairs Agency Review Team. Read more
David A. Putnam, professor of biomedical engineering, and Matthew P. DeLisa, the William L. Lewis Professor of chemical and biomolecular engineering, recently garnered $17.9 million from the National Institutes of Health to develop their idea for an ingenious new vaccine technology. Read more
Hot off the press! We are pleased to share with you the annual Cornell BME newsletter, highlighting innovative biomedical engineering research, educational activities, and more. Read more
Congratulations to the following Meinig School students on being pinned Dean's Scholars at the 2020 event: Read more
An intercampus research team has been awarded a five-year, $3.65 million grant from the National Institutes of Health to develop a quick, inexpensive method for accurately diagnosing urinary tract infections in kidney transplant patients. Read more
A $2 million grant from the National Science Foundation will fund research, led by Nicholas Abbott from the Smith School of Chemical and Biomolecular Engineering, into “microcleaners” for waterways. Read more
Cornell engineers have developed a new framework that makes the design of stretchy elastomers a modular process, allowing for the mixing and matching of different metals with a single polymer. Read more
Learn more about Prof. Karl Lewis, and assistant professor who started at the Meinig School in July, in this Cornell Daily Sun article. Read more
Cornell Research article features Meinig School Prof. David Putnam's (with Ph.D. student Mariela Rivera de Jesus) work adapting their lab's flu vaccine technology to address COVID-19 . Read more
